The 40th Congress of the International Society of Gynecologic Endocrinology (ISGE) took place from March 4 to 6, 2026, in Rome, Italy. The event brought together international experts from the fields of gynecology, gynecologic oncology, obstetrics, and endocrinology to discuss current scientific developments, clinical findings, and future perspectives in the field.
On the occasion of its 50th anniversary, SELFAGO held its own scientific session. During this session, Prof. Dr. R. Druckmann was first honored with the presentation of the “Pour le Mérite” medal and the “Certificat D’honneur” for his decades of service to the society. The following scientific contributions were presented during the session:
The improved long-term outcome in denosumab-treated breast cancer patients is driven by progesterone receptor status
Managing premature menopause after gynecologic cancer: balancing hormonal safety and quality of life
Adjuvant chemotherapy and its impact on overall survival in endometrial carcinoma: a retrospective cohort study of 5,000 patients from Bavaria, Germany (2017–2023)
Paradigm shift in the management of advanced ovarian cancer, the impact of neoadjuvant treatment
The contributions of the SELFAGO session and the lively discussion demonstrated the great interest in the topics covered and underscore the society’s continuous scientific work as well as its perspectives for the future development of the field.
In his closing remarks, the President of the Society, Prof. Dr. Walther Kuhn, emphasized the importance of collaboration between experienced members and the younger generation:
“I am grateful that in SELFAGO, experienced members are shaping further development and advancing the society together with the young generation.”